-
Diagnostics World News | Scientists at the Mayo Clinic are applying artificial intelligence (AI) to pick up auditory signals of heart health undetectable by the human ear, notably subtle acoustic changes that might not be intuitive or formally taught in medical school or during residency and fellowship training. Their vocal biomarker is based on the supposition that cardiovascular disease is likely expressed throughout the body at large, including the phonatory system.
Apr 7, 2022
-
Diagnostics World | Researchers are currently exploring various approaches to pan-cancer testing, including the measurement of changes in DNA or RNA sequences, patterns of DNA methylation or fragmentation, levels of protein biomarkers, and antibodies, among others. For now, it remains to be seen which of these differing routes will lead to the most effective method or methods.
Apr 5, 2022
-
Diagnostics World | Funding for PCR-based in-home medical diagnostics, microcarriers for cell-based assays, higher-order protein structural analysis, 3D genomics, AI-powered single-cell analysis, and more.
Mar 31, 2022
-
Diagnostics World News | A genomic network model is used to identify aurora kinase inhibitor-sensitive lung tumors, AI seeks to improved prostate cancer diagnosis and prognosis, improved liver cancer detection is achieved with simple blood test, immunohistochemistry analysis standardization, and PacBio and Sick Kids in Toronto are working to identify genetic variants responsible for childhood disease using HiFi WGS.
Mar 30, 2022
-
Diagnostics World News | Biology and technology have finally advanced to the point where a teentsy device for imaging the inside of the fallopian tubes is recognized both as an unmet clinical need and a plausible engineering feat. Introducing the falloposcope, intended to search for signs of early-stage ovarian cancer and currently undergoing pilot testing in volunteers having their tubes removed for reasons other than cancer to establish a baseline for normal.
Mar 29, 2022
-
Diagnostics World News | As the global COVID-19 battle wages on, the ‘silent pandemic’ of antimicrobial resistance (AMR) continues to expand around the world. As the medical community continues to evaluate new technology-based approaches to fight AMR, microbial genome sequencing coupled with artificial intelligence (AI) are among the first topics brought up for discussion, and many laboratories are already embracing these new technologies.
Mar 25, 2022
-
Diagnostic World News | Hundreds of clinical trials are underway testing therapies for treatment-resistant depression (TRD), yet until very recently there was not a clear definition of what is even being treated. But with newly proposed criteria to describe the condition, researchers and regulatory agencies have a basis for agreement that could help inform study design and potentially improve the lives of millions of people worldwide.
Mar 23, 2022
-
Diagnostics World News | Merging biotech and infotech, life science company Karius has laid the groundwork for dramatically advancing molecular diagnostics for infectious diseases on a global scale, according to Chief Medical Officer (CMO) Brad Perkins, M.D. Using technology similar to what’s being used for detecting circulating tumor DNA, the Karius “liquid biopsy” test looks for microbial cell-free DNA (cfDNA) to accurately identify more than 1,000 pathogens from a single blood draw.
Mar 18, 2022
-
Diagnostics World | In recent years, the race to develop a single test that can simultaneously screen for many cancers has heated up. Dozens of companies have thrown their hats in the ring, pursuing differing approaches to search for the very earliest signs of cancer. So where does this field currently stand? Where is it headed? And is extremely early cancer detection really possible?
Mar 16, 2022